AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildaspec M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Spectra Therapeutics Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildaspec M 500mg/50mg Tablet

Combiflor 500mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially minimizing the risk of cardiovascular events. Combiflor 500mg/50mg may be administered independently or in conjunction with other antidiabetic therapies. Optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is tailored to individual needs, encompassing current health status, glycemic control, and concurrent medications. Ingestion with meals mitigates gastrointestinal discomfort. Consistent daily dosing maximizes therapeutic benefits; discontinuation should only occur under medical guidance. Effective blood sugar regulation minimizes the risk of future complications. Continued commitment to the prescribed dietary and exercise regimen is crucial. Lifestyle modifications are integral to diabetes management. Commonly reported side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; prompt recognition and management are essential. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before initiating treatment. Potential drug interactions necessitate a comprehensive disclosure of all medications to your physician to ensure patient safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted by your doctor throughout the treatment period.

Primary Ingredients of Vildaspec M 500mg/50mg Tablet

No text was provided to rewrite.

Uses of Vildaspec M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vildaspec M 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Vildaspec M 500mg/50mg tablet whole; avoid chewing, crushing, or fracturing it. Take this medication with a meal.

Common Side effects of Vildaspec M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildaspec M 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Vildaspec M 500mg/50mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with a meal.

How Vildaspec M 500mg/50mg Tablet works:

The antidiabetic drug Vildaspec M, available as a 500mg/50mg tablet, contains a dual-agent formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildaspec M 500mg/50mg Tablet with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vildaspec M 500mg/50mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildaspec M 500mg/50mg tablets while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Vildaspec M 500mg/50mg tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Vildaspec M 500mg/50mg tablets due to potential safety risks. Medical advice is recommended.

What if you forget to take Vildaspec M 500mg/50mg Tablet :

Should you forget to take a Vildaspec M 500mg/50mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildaspec M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Vildaspec M 500mg/50mg Tablet

Vildaspec M 500mg/50mg Tablets rarely cause hypoglycemia by themselves; however, low blood sugar can result from inadequate calorie intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate hypoglycemia. These symptoms are more pronounced if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildaspec M 500mg/50mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take additional medication without your doctor's approval.
Vildaspec M 500mg/50mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildaspec M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildaspec M 500mg/50mg Tablets can, rarely, cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving excessive blood lactic acid. This risk is heightened in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Vildaspec M 500mg/50mg Tablets can lead to Vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildaspec M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with proper use, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent side effects to your physician.
Vildaspec M 500mg/50mg Ta...
84
MRP 97
13% off